Deborah Marriott

9.9k total citations · 1 hit paper
149 papers, 6.8k citations indexed

About

Deborah Marriott is a scholar working on Infectious Diseases, Epidemiology and Parasitology. According to data from OpenAlex, Deborah Marriott has authored 149 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Infectious Diseases, 57 papers in Epidemiology and 42 papers in Parasitology. Recurrent topics in Deborah Marriott's work include Antifungal resistance and susceptibility (40 papers), Parasitic Infections and Diagnostics (40 papers) and Amoebic Infections and Treatments (27 papers). Deborah Marriott is often cited by papers focused on Antifungal resistance and susceptibility (40 papers), Parasitic Infections and Diagnostics (40 papers) and Amoebic Infections and Treatments (27 papers). Deborah Marriott collaborates with scholars based in Australia, United States and Italy. Deborah Marriott's co-authors include John Ellis, Damien Stark, J. Harkness, Tania C. Sorrell, John Harkness, Joel Barratt, David Ellis, Andrew Field, Monica A. Slavin and John E. Ray and has published in prestigious journals such as The Lancet, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Deborah Marriott

146 papers receiving 6.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#

2020 640 citations Jan‐Willem C. Alffenaar, Deborah Marriott et al. profile →

Peers

Countries citing papers authored by Deborah Marriott

Since Specialization

Citations

This map shows the geographic impact of Deborah Marriott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Marriott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Marriott more than expected).

Fields of papers citing papers by Deborah Marriott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah Marriott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Marriott. The network helps show where Deborah Marriott may publish in the future.

Co-authorship network of co-authors of Deborah Marriott

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah Marriott. A scholar is included among the top collaborators of Deborah Marriott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah Marriott. Deborah Marriott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Towards model-informed precision dosing of intravenous linezolid: a multicentre external evaluation of pharmacokinetic models in critically ill adults 2025 ·Clinical Microbiology and Infection ·(unknown), (unknown), Michael Zöller, Christina Scharf, Johannes Zander, Michael Paal, (unknown), (unknown), (unknown), (unknown), (unknown), Jörn Grensemann, (unknown), (unknown), Deborah Marriott, Sophie L. Stocker, Sebastian G. Wicha, Uwe Liebchen	0
2	It cuts both ways: A single-center retrospective review describing a three-way interaction between flucloxacillin, voriconazole and tacrolimus 2023 ·International Journal of Antimicrobial Agents ·Fay Burrows, (unknown), Jana Stojanova, Deborah Marriott	1
3	Effect of Therapeutic Plasma Exchange on Itraconazole Pharmacokinetics: A Case Study 2023 ·Therapeutic Drug Monitoring ·(unknown), (unknown), (unknown), Stephanie E. Reuter, (unknown), Deborah Marriott, Sophie L. Stocker	0
4	Are vancomycin dosing guidelines followed? A mixed methods study of vancomycin prescribing practices 2021 ·British Journal of Clinical Pharmacology ·Jane E. Carland, Sophie L. Stocker, Melissa Baysari, Crystal Li, (unknown), (unknown), Sarah Si Lin Tang, Indy Sandaradura, (unknown), (unknown), Kenneth M. Williams, Deborah Marriott, Richard O. Day	18
5	Model-Optimized Fluconazole Dose Selection for Critically Ill Patients Improves Early Pharmacodynamic Target Attainment without the Need for Therapeutic Drug Monitoring 2021 ·Antimicrobial Agents and Chemotherapy ·Indy Sandaradura, (unknown), Deborah Marriott, Richard O. Day, Sophie L. Stocker, Stephanie E. Reuter	5
6	Would they trust it? An exploration of psychosocial and environmental factors affecting prescriber acceptance of computerised dose‐recommendation software 2020 ·British Journal of Clinical Pharmacology ·Jane E. Carland, (unknown), Melissa Baysari, Sophie L. Stocker, Deborah Marriott, Natalie Taylor, Richard O. Day	15
7	Evaluation of amikacin use and comparison of the models implemented in two Bayesian forecasting software packages to guide dosing 2020 ·British Journal of Clinical Pharmacology ·(unknown), Jane E. Carland, Robert C. McLeay, (unknown), Deborah Marriott, Richard O. Day, Sophie L. Stocker	8
8	Evaluation of a Pilot Vancomycin Precision Dosing Advisory Service on Target Exposure Attainment Using an Interrupted Time Series Analysis 2020 ·Clinical Pharmacology & Therapeutics ·Sophie L. Stocker, Jane E. Carland, Stephanie E. Reuter, Alexandra E. Stacy, Andrea L. Schaffer, Maurizio Stefani, (unknown), (unknown), Jennifer Yang, (unknown), Darren M. Roberts, Deborah Marriott, Richard O. Day, Jonathan Brett	18
9	Therapeutic Drug Monitoring Can Improve Linezolid Dosing Regimens in Current Clinical Practice: A Review of Linezolid Pharmacokinetics and Pharmacodynamics 2019 ·Therapeutic Drug Monitoring ·Gauri G. Rao, (unknown), Dario Cattaneo, Jan‐Willem C. Alffenaar, Deborah Marriott, Michael Neely	82
10	The Prevalence of Angiostrongylus cantonensis/mackerrasae Complex in Molluscs from the Sydney Region 2015 ·PLoS ONE ·Douglas Chan, Joel Barratt, Tamalee Roberts, Rogan Lee, Michael Shea, Deborah Marriott, J. Harkness, Richard Malík, Malcolm K. Jones, Mahdis Aghazadeh, John Ellis, Damien Stark	34
11	Not Just Little Adults: Candidemia Epidemiology, Molecular Characterization, and Antifungal Susceptibility in Neonatal and Pediatric Patients 2009 ·PEDIATRICS ·Christopher C. Blyth, Wen Chen, Monica A. Slavin, Carolina Serena, Quoc Nguyen, Deborah Marriott, David Ellis, Wieland Meyer, Tania C. Sorrell, (unknown)	151
12	Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management 2009 ·Clinical Microbiology and Infection ·S.C.A. Chen, Deborah Marriott, E. Geoffrey Playford, Quoc Nguyen, David Ellis, Wieland Meyer, Tania C. Sorrell, Monica A. Slavin	81
13	Voriconazole concentrations and outcome of invasive fungal infections 2009 ·Clinical Microbiology and Infection ·Spiros Miyakis, Sebastiaan J. van Hal, John E. Ray, Deborah Marriott	131
14	Repeated Dientamoeba fragilis infections: a case report of two families from Sydney, Australia 2009 ·Infectious Disease Reports ·Damien Stark, Joel Barratt, John Ellis, J. Harkness, Deborah Marriott	11
15	Comparison of Stool Antigen Detection Kits to PCR for Diagnosis of Amebiasis 2008 ·Journal of Clinical Microbiology ·Damien Stark, Sebastian van Hal, Rashmi Fotedar, Andrew Butcher, Deborah Marriott, John Ellis, J. Harkness	62
16	Candidemia in nonneutropenic critically ill patients: Risk factors for non-albicans Candida spp. 2008 ·Critical Care Medicine ·E Geoffrey Playford, Deborah Marriott, Quoc Nguyen, Wen Chen, David Ellis, Monica A. Slavin, Tania C. Sorrell	114
17	MRSA detection: comparison of two molecular methods (BD GeneOhm® PCR assay and Easy-Plex) with two selective MRSA agars (MRSA-ID and Oxoid MRSA) for nasal swabs 2008 ·European Journal of Clinical Microbiology & Infectious Diseases ·S. J. van Hal, (unknown), D. Stark, Deborah Marriott, John Harkness	20
18	Active Surveillance of Candidemia, Australia 2006 ·Emerging infectious diseases ·Sharon Chen, Monica A. Slavin, Quoc Nguyen, Deborah Marriott, E. Geoffrey Playford, David Ellis, Tania C. Sorrell, (unknown)	140
19	Microsporidial keratoconjunctivitis in AIDS 1993 ·Eye ·Peter McCluskey, (unknown), Deborah Marriott, Andrew Field	20
20	Low-Dose Trimethoprim-Sulfamethoxazole Prophylaxis for Toxoplasmic Encephalitis in Patients with AIDS 1992 ·Annals of Internal Medicine ·Andrew Carr, Brett Tindall, Bruce J. Brew, Deborah Marriott, John Harkness, Ronald Penny, David A. Cooper	163

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact